KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 123 filers reported holding KEROS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $406,730 | -31.0% | 8,900 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $589,180 | +51.5% | 8,900 | -27.0% | 0.00% | 0.0% |
| Q3 2023 | $388,936 | -20.7% | 12,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $490,196 | -5.9% | 12,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $520,940 | -33.0% | 12,200 | -24.7% | 0.00% | -50.0% |
| Q4 2022 | $777,924 | +13.6% | 16,200 | -11.0% | 0.00% | +100.0% |
| Q3 2022 | $685,000 | -80.7% | 18,200 | -85.8% | 0.00% | -66.7% |
| Q2 2022 | $3,544,000 | -13.6% | 128,277 | +70.1% | 0.00% | 0.0% |
| Q1 2022 | $4,100,000 | +47.2% | 75,391 | +57.6% | 0.00% | +50.0% |
| Q4 2021 | $2,786,000 | – | 47,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |